Ondine Biomedical CEO Carolyn Cross joined Steve Darling from Proactive to share news about the company that is on a mission to improve outcomes in hospitals when it comes to dealing with infections.
Cross talks about their patented, painless, photodisinfection technology platform for the prevention of broad-spectrum pathogens which are bacterial, viral and fungal. That process involves a two-step process with the application of a laser light-activated agent to each nostril, followed by illumination of the area via laser light for less than five minutes.